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Abstract
Background: Laboratory testing in clinical practice is never a random process. In this study we evaluated testing bias 
for neutrophil counts in clinical practice by using results from requested and non-requested hematological blood tests.
Methods: This study was conducted using data from the Utrecht Patient Oriented Database. This clinical database is 
unique, as it contains physician requested data, but also data that are not requested by the physician, but measured as 
result of requesting other hematological parameters. We identified adult patients, hospitalized in 2005 with at least two 
blood tests during admission, where requests for general blood profiles and specifically for neutrophil counts were 
contrasted in scenario analyses. Possible effect modifiers were diagnosis and glucocorticoid use.
Results: A total of 567 patients with requested neutrophil counts and 1,439 patients with non-requested neutrophil 
counts were analyzed. The absolute neutrophil count at admission differed with a mean of 7.4 × 109/l for requested 
counts and 8.3 × 109/l for non-requested counts (p-value < 0.001). This difference could be explained for 83.2% by the 
occurrence of cardiovascular disease as underlying disease and for 4.5% by glucocorticoid use.
Conclusion: Requests for neutrophil counts in clinical databases are associated with underlying disease and with 
cardiovascular disease in particular. The results from our study show the importance of evaluating testing bias in 
epidemiological studies obtaining data from clinical databases.
Background
In recent years, large health care databases are increas-
ingly used and provide important tools in epidemiologi-
cal research [1,2]. Advantages are that large amounts of
clinical data are available at relatively low cost, and that
these databases usually reflect daily practice [3,4]. How-
ever, in contrast to randomized clinical trials, where data
collection is well-controlled, bias should always be con-
sidered when using routinely collected data in automated
databases and methodological issues should be taken into
account [3,5-7].
Laboratory testing in clinical practice is never a random
process, as the physician has reasons to perform a test.
Physicians selectively request tests for patients with a
high probability of abnormalities and less frequently for
patients with a low probability, because of patient burden
and costs [8]. Such selective processes might induce test-
ing bias in clinical database studies. There are several
strategies to minimize testing bias, including selection of
proper patient populations, measuring outcomes for all
study participants, blind testing, or using imputation
techniques to deal with missing data [8-10], but these
techniques do not provide insight into size and direction
of testing bias.
One example where testing bias might occur is in phy-
sicians' requests of blood tests. Neutrophil counts in
peripheral blood are considered a useful biomarker for
disease severity in many conditions [11-14]. However,
testing bias might occur because of underlying disease or
medication use, as neutrophil counts differ in several dis-
eases and clinical observations have shown that patients
using glucocorticoids often have higher neutrophil
counts. Requesting neutrophil counts specifically for cer-
tain diseases or for glucocorticoid users might cause test-
ing bias in clinical databases. The aim of this study was to
evaluate testing bias for neutrophil counts in clinical
practice by using results from requested and non-
requested hematological blood tests.
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Methods
Setting
This study was conducted using data from the Utrecht
Patient Oriented Database (UPOD). UPOD is an infra-
structure of relational databases comprising administra-
tive data on patient characteristics, laboratory test
results, medication orders, discharge diagnoses and med-
ical procedures for all patients treated at the University
Medical Center (UMC) Utrecht, a 1,042-bed tertiary
teaching hospital in the center of the Netherlands. Each
year, approximately 165,000 patients are treated during
more than 28,000 hospitalizations, 15,000 day-care treat-
ments, and 334,000 outpatient visits. UPOD data acquisi-
tion and data management is in accordance with current
Dutch privacy and ethical regulations. A more complete
description of UPOD has been published elsewhere [15].
UPOD is a unique clinical database as it contains
results of hematological blood tests measured with Cell-
Dyn Sapphire automated blood cell analyzers (Abbott
Diagnostics, St. Clara, California, USA) [15]. A feature of
this analyzer is that it measures all hematological param-
eters irrespective of whether these are requested or not
[15]. The non-requested parameters are measured
because one hematological test is technically linked to the
other hematological tests and conducted automatically
when one of these tests is requested. In other words,
UPOD contains requested (Figure 1) and non-requested
test results (Figure 2). Although non-requested neutro-
phil counts are not reported to the clinician, these neu-
trophil counts are collected in UPOD.
Scenarios
By comparing the measured hematological parameters
with the routine hospital laboratory reporting system,
which reports laboratory results to physicians, neutrophil
counts can be categorized as requested or non-requested.
Neutrophil counts appearing in the laboratory reporting
system were categorized as requested; other neutrophil
counts were categorized as non-requested. Using these
data, we conducted two scenario analyses. Scenario 1
reflects the situation as in a typical clinical database,
where all blood tests were requested. With scenario 2 we
were able to study testing bias by including non-
requested blood tests in our analysis.
Study population
The source population comprised 3,467 adult (18 years or
older) users and non-users of glucocorticoids who were
hospitalized in the UMC Utrecht in 2005 and had at least
two hematological blood tests, where these tests should
cover at least a one-day period. For each glucocorticoid
user, the first blood test during admission and the last
blood measurement during in-hospital glucocorticoid
use were selected for analysis. Up to four unexposed
p a t i e n t s  w e r e  s a m p l e d  t o  e a c h  g l u c o c o r t i c o i d  u s e r
according to calendar time (with a maximum of 15 days
before or after the test date of the user), neutrophil count
at time of admission (max 2 × 109 neutrophils/l around
the neutrophil count of the user) and days between the
two blood samples (max two days around the number of
days for the glucocorticoid user). According to our labo-
ratory normal reference range for neutrophils (1.6-8.3 ×
109/l), there is large inter-individual variation in the abso-
lute neutrophil count. Using two blood tests, we were
able to study testing bias in both blood tests separately,
but also in the change in neutrophil count during hospi-
talization for each patient. Within the source population,
we contrasted patients with both blood tests requested
and with both blood tests non-requested, one at time of
admission and one at the end of hospitalization. For all
participants the discharge diagnosis was defined accord-
ing to the ICD-9-CM code [16].
Data analysis
Student t-tests, Mann-Whitney tests, and chi-square
tests were used to test for differences between groups, as
appropriate. Confounding was studied using logistic
regression. The absolute neutrophil count was catego-
rized into tertiles to obtain three equally-sized groups.
These three groups were defined as an increase, decrease
or no change in neutrophil count where no change was
the comparator group. Potential confounding factors
were included in a multivariable logistic model in
sequence with decreasing confounding strength. Poten-
tial confounders that were studied were age, gender, num-
ber of days between blood samples, length of
hospitalization, death during hospitalization, and diagno-
sis. All variables that changed the regression coefficient
for glucocorticoid use by less than ten percent were
excluded from the model. Of these potential confound-
ers, only diagnosis had a substantial effect on the compar-
ison between scenarios. Glucocorticoid use was studied
because of the ongoing discussion about the effect of glu-
cocorticoids on the neutrophil count [12,17,18]. Subse-
quently, linear regression analysis was used to estimate
the proportion of bias associated with diagnostic sub-
groups and glucocorticoid use. The beta-coefficient for
the contrasted scenarios was calculated for all patients in
the study population as well as for only patients exposed
to one factor (for example a diagnostic subgroup or glu-
cocorticoid use). The proportion of bias explained by one
factor was calculated as the weighted fraction of beta-
coefficients. All analyses were conducted using SPSS for
Windows, version 14.0 (SPSS Inc., Chicago, Illinois,
USA).Velthove et al. Emerging Themes in Epidemiology 2010, 7:2
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Results
A total of 567 patients with requests for the absolute neu-
trophil count (scenario 1) and 1,439 patients with non-
requested neutrophil counts (scenario 2) were identified.
It appeared that the absolute neutrophil count was most
frequently requested in the context of a leukocyte differ-
ential request, which includes the absolute counts of neu-
trophils, eosinophils, lymphocytes, monocytes, and
basophils (99.8% of all neutrophil count requests). Of
patients with requested neutrophil counts, there was also
a hemoglobin request for 97.2% of patients. For patients
with non-requested neutrophil counts, 96.1% of the
requests were for hemoglobin. Hemoglobin values were
lower when requested compared with non-requested
hemoglobin values (Table 1).
For the first blood test, lower neutrophil counts were
found for patients with requested neutrophil counts com-
pared with non-requested neutrophil counts (Table 1).
Comparable neutrophil counts were found in the second
blood test. For both blood tests, there were more patients
with neutropenia and fewer patients with neutrophilia for
requested neutrophil counts. Studying the change in the
absolute neutrophil count during hospitalization for each
patient, patients with non-requested neutrophil counts
had a mean decrease of 0.50 × 109 neutrophils/l com-
pared with a slight increase of 0.14 × 109 neutrophils/l for
patients with requested neutrophil counts (p-value 0.008,
Table 1, Figure 3).
Overall, the main diagnostic subgroups were cardiovas-
cular disease (28.9%), neoplasms (14.5%), and respiratory
disease (4.5%). Requests for neutrophil counts were more
often conducted for patients suffering from cardiovascu-
lar or respiratory diseases, whereas diagnoses for non-
requested neutrophil counts were much more diffuse
with multiple diagnoses (Table 1). There were no differ-
ences in absolute neutrophil count or change in neutro-
phil counts among patients with neoplasms and
respiratory disease (Table 2). However, among patients
with cardiovascular disease there was a lower absolute
neutrophil count in the first blood test for requested
counts compared with non-requested neutrophil counts.
Excluding cardiovascular patients from analysis, the
Figure 1 Illustration of scenarios. Scenario 1 represents the situation in a typical clinical database where all neutrophil counts were requested by 
physicians.
Physician request
for absolute
neutrophil count
Laboratory system reporting only
the absolute neutrophil count
Result to physician
All parameters collected in
UPOD database
Neutrophil count requested
Leukocytes Hemoglobin Erythrocytes
Neutrophils Thrombocytes
Other
parameters
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absolute neutrophil counts in the first blood test were
equal with 8.1 × 109/l in both scenarios (Figure 4). The
difference in absolute neutrophil count between scenar-
ios in the first blood test could be explained for 83.2% by
cardiovascular disease (p-value for effect modification
0.002). Incorporating glucocorticoid use in the linear
regression model showed that diagnosis was far more
important than glucocorticoid use (p-value for effect
modification 0.240). Taking diagnosis into account, 4.5%
of the difference in absolute neutrophil count between
scenarios in the first blood test could be explained by glu-
cocorticoid use.
With respect to the absolute neutrophil count in the
second blood test, there were no differences between the
scenarios, either in the overall analysis or in the main
diagnostic subgroups. An increase in neutrophil count of
2.1 × 109/l was shown for requested neutrophil counts in
cardiovascular patients, whereas non-requested counts
revealed a decrease of 0.4 × 109 neutrophils/l (Table 2).
Excluding cardiovascular disease from analysis, the
change in neutrophil count was comparable in both sce-
narios with a mean decrease of 0.9 × 109/l for each
patient with requested neutrophil counts and a mean
decrease of 0.5 × 109/l for each patient including only
non-requested neutrophil counts (p-value = 0.211).
Discussion
In this study, we used UPOD to study bias in neutrophil
testing, as this database contains both requested and
non-requested neutrophil counts. Among tests for which
neutrophil counts were requested, hemoglobin was also
requested in 97%. For non-requested neutrophil test
results, 96% were generated by hemoglobin requests.
Therefore, hemoglobin requests approximate random
testing and can be used as comparator group. Absolute
neutrophil counts differed for requested tests (scenario 1)
compared with non-requested tests (scenario 2), which
leads to the conclusion that testing bias was found in this
study.
The bias in absolute neutrophil count in the first blood
test could be explained for 83.2% by cardiovascular dis-
ease. This finding could reflect the role of neutrophils in
cardiovascular disease [13,19,20]. After excluding cardio-
vascular disease from analysis, there were no differences
in absolute neutrophil count or change in neutrophil
count for each patient. This could be explained by the fact
Figure 2 Is unique for UPOD as this includes non-requested neutrophil counts. These non-requested neutrophil counts are measured because 
this test is conducted automatically when one hematological test, for example hemoglobin, is requested.
Physician request
for hemoglobin
Laboratory system reporting only
the hemoglobin value
Result to physician
All parameters collected in
UPOD database
Neutrophil count non-requested
Leukocytes Hemoglobin Erythrocytes
Neutrophils Thrombocytes
Other
parameters
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Table 1: Baseline characteristics of the study population*
Characteristic Requested neutrophil 
count (scenario 1)(n = 567)
Non-requested neutrophil 
count (scenario 2)(n = 1,439)
P-value 
(two-sided)
Age, yr 57.8 ± 17.8 56.9 ± 19.0 0.311a
Sex 0.001c
Male 327 (57.7) 715 (49.7)
Female 240 (42.3) 724 (50.3)
Length of hospitalization 10 (7-18) 10 (6-18) 0.807b
Days between blood tests 6 (3-10) 4 (2-8) < 0.001b
Death during hospitalization 36 (6.3) 83 (5.8) 0.610c
Hemoglobin value 1st blood test (mmol/l) 8.0 ± 1.3 7.4 ± 1.4 < 0.001b
Median (IQR) 8.1 (7.2-8.9) 7.4 (6.4-8.4)
Hemoglobin value 2nd blood test (mmol/l) 7.1 ± 1.3 6.9 ± 1.2 < 0.001b
Median (IQR) 7.1 (6.2-8.0) 6.8 (5.9-7.7)
Absolute neutrophil count 1st blood test (109/l) 7.4 ± 4.7 8.3 ± 4.0 < 0.001b
Median (IQR) 6.1 (4.0-9.9) 7.7 (5.3-10.6)
Neutropenia 17 (3.0) 17 (1.2)
Within normal reference area 365 (64.4) 784 (54.5)
Neutrophilia 185 (32.6) 638 (44.3) < 0.001c
Absolute neutrophil count 2nd blood test (109/l) 7.6 ± 4.7 7.8 ± 4.0 0.111b
Median (IQR) 6.8 (4.5-9.5) 7.0 (5.0-9.5)
Neutropenia 20 (3.5) 18 (1.3) 0.003c
Within normal reference area 352 (62.1) 915 (63.6)
Neutrophilia 195 (34.4) 506 (35.2)
Change in neutrophil count for each patient (109/l) 0.14 ± 5.1 -0.50 ± 4.2 0.008a
Glucocorticoid use 174 (30.7) 237 (16.5) < 0.001c
Diagnosis < 0.001c
Neoplasms 71 (12.5) 220 (15.3)
Cardiovascular diseases 200 (35.3) 380(26.4)
Respiratory diseases 53 (9.3) 38 (2.6)
Infectious and parasitic diseases 30 (5.3) 21 (1.5)
Endocrine, nutritional and metabolicdiseases, 
and immunity disorders
30 (5.3) 22 (1.5)
Diseases of the digestive system 26 (4.6) 114 (7.9)
Diseases of the genitourinary system 33 (5.8) 49 (3.4)
Diseases of the skin, subcutaneous tissue, 
musculoskeletal system, and connective 
tissue
18 (3.2) 108 (7.5)
Other 106 (18.7) 487 (33.8)
*Data are presented as n (%), or mean ± SD, or median (interquartile range)
aStudent t-test; bMann-Whitney test; cχ2 test
Scenario 1 includes patients with requested neutrophil counts for both blood tests
Scenario 2 includes patients with non-requested neutrophil counts for both blood testsVelthove et al. Emerging Themes in Epidemiology 2010, 7:2
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that the absolute neutrophil count was mainly requested
in the context of a leukocyte differential count. Similar
findings were observed for the change in neutrophil
count. For the second neutrophil test, no differences were
found between the scenarios. The second neutrophil test
was at the end of hospitalization. The first neutrophil
test, at time of admission, is more informative because
the patients are likely to be severely ill at that point. At
time of the second blood test the difference in absolute
neutrophil count has evened out, as patients are healthier
at the end of hospitalization.
The results of this study are in accordance with other
studies finding that data are not missing at random
[21,22]. Further research is needed to study the clinical
relevance of the bias found in this study. Distributions of
diagnostic subgroups and testing guidelines might vary
between health care institutions. As a consequence, gen-
eralizability of clinical implications, like the association
with cardiovascular disease as an example in this study,
might be limited. However, testing bias is an issue in all
centers and should be evaluated to be able to adjust for
this bias. Using laboratory tests, a random tested parame-
ter, like hemoglobin testing in this study, could serve as
comparator group to study testing bias. With knowledge
about the size and direction of testing bias, strategies
such as imputation techniques [8,21] could adjust for this
bias in order to obtain an unbiased risk estimate in epide-
miological studies.
With development of automated machines for routine
analysis, more parameters are measured than requested.
When these non-requested parameters are collected,
testing randomness is introduced. UPOD contains
requested neutrophil counts and non-requested neutro-
phil counts, as well as other non-requested hematological
blood tests. Therefore, the database is especially suitable
to study and adjust for testing bias in clinical research
questions. Conducting studies with laboratory markers in
UPOD, correction factors for requested testing can be
Figure 3 Absolute neutrophil counts and change in neutrophil count. Distribution of the absolute neutrophil count of the first (A) and second 
blood test (B) and the change in neutrophil count for each patient (C) for requested neutrophil counts (scenario 1) and non-requested neutrophil 
counts (scenario 2). The vertical lines represent the normal reference area of 1.6-8.3 × 109/l for the absolute neutrophil count (A and B).Velthove et al. Emerging Themes in Epidemiology 2010, 7:2
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added to the statistical model to minimize testing bias in
order to obtain an unbiased risk estimate.
A classic example of testing bias is the association
between thrombosis and use of oral contraceptives. Many
studies state traditionally that the size of this association
is overestimated because of diagnostic suspicion bias and
referral bias, both types of testing bias [23,24]. However, a
case-control study with the same referral and diagnostic
strategies for cases and controls, showed that neither type
of bias played a major role in previous studies, and that
the risk of thrombosis while using oral contraceptives is
not solely due to bias [9]. This example and the results
from our study show the importance of evaluating testing
Table 2: Neutrophil counts for the main diagnostic subgroups
Cardiovascular disease
Characteristic Requested (scenario 1) Non-requested (scenario 2) P-value (two-sided)
N 200 (35.3%) 380 (26.4%)
Absolute neutrophil count 1st 
blood test (109/l)
6.3 ± 3.6 8.7 ± 4.0 < 0.001b
Median (IQR) 5.3 (3.9-7.1) 8.2 (5.6-11.2)
Absolute neutrophil count 2nd 
blood test (109/l)
8.4 ± 4.0 8.3 ± 4.0 0.741b
Median (IQR) 7.5 (5.5-9.8) 7.5 (5.4-10.5)
Change in neutrophil count 
for each patient (109/l)
2.1 ± 4.5 -0.4 ± 4.2 < 0.001a
Neoplasms
N 71 (12.5%) 220 (15.3%)
Absolute neutrophil count 1st 
blood test (109/l)
6.6 ± 4.1 7.1 ± 3.6 0.284b
Median (IQR) 6.0 (3.0-10.2) 6.5 (4.6-9.4)
Absolute neutrophil count 2nd 
blood test (109/l)
7.7 ± 5.6 7.5 ± 4.3 0.986b
Median (IQR) 6.9 (4.1-10.6) 6.9 (4.8-9.0)
Change in neutrophil count 
for each patient (109/l)
1.1 ± 5.4 0.5 ± 4.2 0.348a
Respiratory disease
N 53 (9.3%) 38 (2.6%)
Absolute neutrophil count 1st 
blood test (109/l)
10.2 ± 6.0 9.3 ± 4.1 0.646b
Median (IQR) 9.2 (6.3-12.8) 8.7 (6.2-12.0)
Absolute neutrophil count 2nd 
blood test (109/l)
8.9 ± 7.4 8.0 ± 4.0 0.778b
Median (IQR) 7.7 (5.6-9.8) 7.5 (5.5-9.2)
Change in neutrophil count 
for each patient (109/l)
-1.3 ± 6.8 -1.3 ± 4.3 0.991a
*Data are presented as n (%), mean ± SD, or median and interquartile range
a Student t-test; b Mann-Whitney test
Scenario 1 includes patients with requested neutrophil counts for both blood tests
Scenario 2 includes patients with non-requested neutrophil counts for both blood testsVelthove et al. Emerging Themes in Epidemiology 2010, 7:2
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bias in epidemiological studies obtaining data from clini-
cal databases.
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